Prosecution Insights
Last updated: May 29, 2026

Examiner: CAIN, JENNIFER LYNN

Tech Center 1600 • Art Units: 1655

This examiner grants 40% of resolved cases

Performance Statistics

40.0%
Allow Rate
-20.0% vs TC avg
93
Total Applications
+74.2%
Interview Lift
1222
Avg Prosecution Days
Based on 40 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
8.0%
§102 Novelty
73.3%
§103 Obviousness
4.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17781767 ANTI-INFLAMMATORY AGENT FOR INTESTINAL CELL Non-Final OA IDEMITSU KOSAN CO.,LTD.
17772002 INSULIN RESISTANCE INHIBITOR FOR RUMINANT ANIMALS Non-Final OA IDEMITSU KOSAN CO.,LTD.
18030234 METHOD FOR PRODUCING EXTRACT COMPOSITION Final Rejection Kao Corporation
17911241 METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS Non-Final OA DST Pharma, Inc.
18457363 HAIR CARE COMPOSITION AND BANANA FLOWER EXTRACT AND METHOD FOR HAIR CARE USING THE SAME Final Rejection TCI CO., LTD.
18515601 RHODIOLA CRENULATA COMPOSITIONS AND METHODS OF MAKING THE SAME Non-Final OA NutriScience Innovations LLC
18482631 FORMULATION FOR THE PREVENTION AND/OR TREATMENT OF COVID-19 Non-Final OA SERVIDENCE INC.
18268146 NUTRACEUTICAL COMPOUNDS USEFUL IN THE TREATMENT OF CORONAVIRUS DISEASE Non-Final OA THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE
18253484 Yeast B-Glucan Emulsion, Methods and Uses Thereof Non-Final OA AMYRIS BIO PRODUCTS PORTUGAL UNIPESSOAL LDA
18263732 METHOD FOR PROMOTING ANTIOXIDANT ACTIVITY OF PURPLE TEA LEAVES Final Rejection CLEANBEAUTY INC.
17718624 PRE-MOISTENED WIPES FOR USE IN TREATING ANAL RECTAL IRRITATIONS AND DISORDERS Final Rejection HALEON US HOLDINGS LLC
18266396 COMPOSITION COMPRISING SEA CUCUMBER GENITAL GLAND EXTRACT, COMPOUND DERIVED FROM SEA CUCUMBER OVARY EXTRACT, AND USE THEREOF Non-Final OA BENTHIC BIO INC.
17296733 Intact Pea Protein-Based Nutrient Composition Final Rejection Kate Farms, Inc.
18097370 CANNABIS AND MUSHROOM COMPOUNDS INFUSED CONSUMABLES Final Rejection TLCO HOLDINGS INC.
18150984 METHOD FOR INCREASING MELATONIN IN SUBJECT AND REGULATING EXPRESSION OF TPH GENE, DDC GENE, AANAT GENE, AND ASMT GENE BY USING LONGAN FLOWER EXTRACT Final Rejection NUTRAREX BIOTECH CO., LTD.
18067805 COMPOSITION COMPRISING A COMPLEX COMPRISING A CURCUMINOID COMPOUND, AND STEVIOL GLYCOSIDES OR A LICORICE EXTRACT OR A FRACTION THEREOF, AND USES THEREOF Final Rejection BIOTEN CO., LTD
17912106 TRANQUILIZING COMPOSITION Non-Final OA NATURAL ENDOTECH CO., LTD.
17925842 COMPOSITIONS AND COMBINATIONS FOR SUBJECTS SUFFERING FROM ENDOMETRIOSIS Final Rejection GYNOV
17912821 PSILOCYBIN AND PSILOCIN CONTAINING COMPOSITIONS AND METHODS OF USING AND MAKING THE SAME Final Rejection Orthogonal Thinker, Inc.
17946578 TGF-BETA INHIBITION, AGENTS AND COMPOSITION THEREFOR Non-Final OA GMP BIOTECHNOLOGY LIMITED
17905390 Antibacterial Antiviral Pharmaceutical Composition and Application Thereof Non-Final OA Yunnan Baiyao Group Company Limited
17904485 HERBAL PREPARATION FOR PREVENTION AND TREATMENT OF HELICOBACTER PYLORI INFECTION Non-Final OA HerbElixa DOO SREMSKA KAMENICA
17697046 ENDOCANNABINOID MIMETIC AND ANTI-INFLAMMATORY COMPOUND CONTAINING COMPOSITIONS, METHODS OF PREPARATION AND USES THEREOF Final Rejection PHARMA COSMETIX RESEARCH, LLC
17638067 CARNOSIC ACID, CARNOSOL AND ROSMARINIC ACID ISOLATION METHOD Non-Final OA TUBITAK
16564251 EAR SPRAY DEVICE AND EAR PROTECTION COMPOSITION FOR PREVENTING WATER RELATED EAR CANAL DISORDERS Non-Final OA LiquidPro Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month